retatrutide clinical trials obesity Perceived benefits of treatment for with retatrutide: A qualitative study of patients in a phase 2 trial ESC 2024: Retatrutide improves lipid

In fact, the clinical diagnosis of PD requires the presence of bradykinesia accompanied by at least one other motor symptom, such as resting tremor, muscle rigidity, or postural instability

Serum metabolomics reveals irreversible inhibition of fatty acid beta-oxidation through the suppression of PPARalpha activation as a contributing mechanism of acetaminophen-induced hepatotoxicity

Substantial progress in understanding the mechanisms of virus entry into the hepatocyte, replication, and the host immune response has led to the development of new therapeutic agents that target the steps in the viral life cycle

Liraglutide Liraglutide is a GLP-1 receptor agonist administered as a once-daily injection